Roberto Frussa-Filho
Overview
    Explore the profile of Roberto Frussa-Filho including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              86
            
            
              Citations
              800
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Marinho E, Oliveira-Lima A, Reis H, Santos-Baldaia R, Wuo-Silva R, Hollais A, et al.
  
  
    Front Pharmacol
    . 2023 Feb;
          14:1100527.
    
    PMID: 36814501
  
  
           The endocannabinoid system has been implicated in the neurobiology of opioid use disorder. While the CB1 receptor antagonist rimonabant has been shown to block some of the behavioral effects of...
      
2.
        
    
    Libarino-Santos M, de Santana Santos A, Cata-Preta E, Barros-Santos T, Nunes Brandao N, Borges A, et al.
  
  
    Drug Alcohol Depend
    . 2020 Jan;
          208:107856.
    
    PMID: 31954952
  
  
          Background: Evidence suggests that aripiprazole, a partial dopamine D2 and serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist, show significant efficacy in reducing alcohol use. We have previously demonstrated that...
      
3.
        
    
    Wuo-Silva R, Fukushiro-Lopes D, Fialho B, Hollais A, Santos-Baldaia R, Marinho E, et al.
  
  
    Front Pharmacol
    . 2019 Mar;
          10:211.
    
    PMID: 30914950
  
  
          Studies on the abuse potential of modafinil, a psychostimulant-like drug used to treat narcolepsy, are still controversial. While some studies claim no potential for abuse, increasing evidence suggests that modafinil...
      
4.
        
    
    Trombin T, Procopio-Souza R, Kameda S, Zanlorenci L, Fukushiro D, Calzavara M, et al.
  
  
    Pharmacol Biochem Behav
    . 2018 Jul;
          173:90-95.
    
    PMID: 30031027
  
  
          Opioid addiction is a growing public health problem, being currently considered an epidemic in the United States. Investigating the behavioral effects of opioids and the factors influencing their development becomes...
      
5.
        
    
    Berro L, Tufik S, Frussa-Filho R, Andersen M, Tufik S
  
  
    Neurosci Lett
    . 2018 Feb;
          671:29-32.
    
    PMID: 29421538
  
  
          Sleep deprivation (SD) and amphetamine use are commonly associated conditions. SD shares similar neurobiological effects with psychostimulants, playing an important role in drug addiction, especially through conditioning manipulations. The aim...
      
6.
        
    
    Marinho E, Oliveira-Lima A, Yokoyama T, Santos-Baldaia R, Ribeiro L, Baldaia M, et al.
  
  
    Pharmacol Biochem Behav
    . 2017 Apr;
          156:16-23.
    
    PMID: 28366798
  
  
          CB1 receptor antagonists have been shown to prevent acute and long-term behavioral effects of cocaine. Here we evaluate the effectiveness of the CB1 receptor antagonist rimonabant to modify sensitized responses...
      
7.
        
    
    Wuo-Silva R, Fukushiro D, Hollais A, Santos-Baldaia R, Mari-Kawamoto E, Berro L, et al.
  
  
    Front Pharmacol
    . 2016 Nov;
          7:420.
    
    PMID: 27872594
  
  
          There is substantial controversy about the addictive potential of modafinil, a wake-promoting drug used to treat narcolepsy, proposed as pharmacotherapy for cocaine abuse, and used indiscriminately by healthy individuals due...
      
8.
        
    
    Esteves A, Lopes C, Frank M, Arida R, Frussa-Filho R, Tufik S, et al.
  
  
    Brain Res
    . 2016 Mar;
          1639:47-57.
    
    PMID: 26923163
  
  
          The purpose of the present study was to determine whether physical exercise (PE) has a protective effect in an experimental animal model of sleep-related movement disorder (A11 dopaminergic nuclei lesions...
      
9.
        
    
    Oliveira de Almeida W, Esteves A, Leite de Almeida-Junior C, Lee K, Frank M, Mariano M, et al.
  
  
    Sleep Sci
    . 2015 Oct;
          7(4):203-8.
    
    PMID: 26483930
  
  
          Long-term treatments with dopaminergic agents are associated with adverse effects, including augmentation. Augmentation consists of an exacerbation of restless legs syndrome (a sleep-related movement disorder) symptoms during treatment compared to...
      
10.
        
    
    Borcoi A, Patti C, Zanin K, Hollais A, Santos-Baldaia R, Ceccon L, et al.
  
  
    Prog Neuropsychopharmacol Biol Psychiatry
    . 2015 Jun;
          63:63-9.
    
    PMID: 26051209
  
  
          Background: Prenatal environmental adversities may affect brain development and are associated with increased risk for schizophrenia, an illness with 50% comorbidity with addiction. Maternal immune activation by poly-inosinic-citidilic acid (Poly(I:C))...